.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Emerald Bay Extracts is stocked at 356 licensed dispensaries across California and New Mexico, 347 of them in California, with the deepest coverage in Los Angeles, Sacramento, San Diego, San Francisco, and Santa Rosa. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In August 2026, Emerald Bay Extracts concentrated 68.92% of sales in Capsules with 71.20% year-over-year growth and a 2.32% month-over-month increase, while Concentrates held 16.43% share with 0.68% year-over-year and a -3.41% month-over-month decline. Tincture & Sublingual accounted for 14.65% share, surging 131.41% year-over-year but dropping -22.03% month-over-month, and the brand’s overall sales rose 58.97% year-over-year alongside a 1.78% year-over-year lift in average price to $34.34. Holding the number 1 rank in Capsules in California while posting a 24-month sales decline of -24.86% implies a mix pivot where near-term growth is being pulled by Capsules and Tincture & Sublingual volatility, not a broad-based expansion across all lines.
The pattern suggests Emerald Bay Extracts is leaning into a Capsules-led positioning, where a number 1 rank in California and a 68.92% category share within the portfolio provide pricing room even as average price only rose 1.78% year-over-year and Concentrates slipped -3.41% month-over-month. With Tincture & Sublingual up 131.41% year-over-year but down -22.03% month-over-month, and Concentrates nearly flat year-over-year at 0.68%, the brand’s durable edge likely resides in Capsules scale and rank stability rather than breadth, implying that sustaining August 2026 momentum will depend on defending Capsules while selectively stabilizing the more volatile Tincture & Sublingual mix.
Competitive Landscape
Emerald Bay Extracts is ranked #1 in California Capsules in August 2026, up 5 positions YoY from #6, and up 3 positions vs May 2026 when it sat at #4; this ascent coincides with Level sliding from #1 YoY to #5 with a 59.3% sales decline and Breez holding #2 while contracting 25.6% YoY, while Buddies advanced to #4 with 32.9% YoY growth but still trails by two rank positions. With ABX / AbsoluteXtracts anchored at #3 despite a 2.7% YoY dip and Emerald Bay Extracts achieving its peak rank of #1 in August 2026, the pattern implies a leadership window created more by competitor retrenchment than category expansion, signaling that maintaining #1 will require defending against Buddies’ positive momentum while capitalizing on rivals’ double‑digit declines.
Notable Products
Blue Dream RSO Tablets 40-Pack (1000mg) posted the steepest decline at -39.5% month over month, sliding to rank 5 while Blue Dream RSO Syringe (1g) fell -28.1% at rank 6. In parallel, Permanent Marker RSO Tablets 10-Pack (1000mg) rose 9.7% to hold rank 1 and Ice Cream Cake RSO Syringe (1g) gained 19.7% at rank 3, indicating share is consolidating at the top around formats with steadier repeat behavior. With six of the top ten SKUs in Capsules and three in Concentrates, the portfolio skews toward ingestible RSO even as select syringes gain rank, implying Emerald Bay Extracts is leaning into RSO-led form factors while pruning underperforming Blue Dream variants.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
